These are very disturbing times for those of us who advocate the orderly and progressive reduction, refinement and replacement of animal experimentation via a case-by-case evaluation of the necessity for performing animal procedures, in the light of the potential benefit which might result and the likely suffering to animals which would be involved.
I had mixed feelings when I heard, on 27 January 2004, that Cambridge University had abandoned plans to build a new centre for neuroscience research on non-human primates. Part of me was relieved, although I recognised that the decision had nothing to do with my editorial in the December 2003 issue of ATLA (Please don't build the Cambridge laboratory! 1 ), which didn't appear until later. However, I was also apprehensive about the backlash which might follow -and which did.
The University's Pro-Vice-Chancellor, Professor Tony Minton, made it clear that the decision was primarily a result of the increase in the projected cost of the laboratory from £24m to £32m, 2 but, not surprisingly, spokespersons for protagonists such as the Association of the Pharmaceutical Industry, the Medical Research Council (MRC), the Research Defence Society (RDS) and the Wellcome Trust, together with the broadsheet and tabloid newspapers, put the blame squarely on militant animal rights campaigners, described by The Times as "sinister extremists who strike at will". 3 They also paraded all the expected propaganda about research on primates being vital to progress in tackling every neurological disease as yet identified (and, presumably, all those not yet known to us), and leading scientists being driven abroad to do their essential work elsewhere.
Nevertheless, it also transpired that ways will be found of continuing the research elsewhere, as was made clear by the MRC and the Wellcome Trust, 4 as well as by John Prescott, the Deputy Prime Minister. 5
Greater Protection from the Law?
Of particular concern is that the decision about the proposed Cambridge laboratory is being used to put pressure on the Government to introduce new legislation to "ensure that this small group of animal rights extremists is stopped from holding UK medical research to ransom", 6 with the support of some rather hysterical press coverage (for example, Rise of suburban terrorist (sic) has British scientists on the run 7 ).
Leading the calls for tougher laws and stronger policing is Huntingdon Life Sciences (HLS), which has long been the focus of the attention of Stop Huntingdon Animal Cruelty (SHAC). Oddly, however, when it was announced that Securicor would not be seeking to renew its contract to protect HLS beyond 31 March 2004, Brian Cass, once-battered Chief Executive of HLS, said that the regional offices of Securicor had endured only "a few ladies with placards and a bit of noise". 8 Thus, just as one man's terrorist is another man's freedom fighter, it appears that those whom some see as sinister extremists can be viewed by others as mere noisy ladies. FRAME has consistently spoken out against extremism of all kinds. However, the unacceptable behaviour of a small group of extremists must not be used to secure either the prevention of legitimate campaigning or the granting of freedom to biomedical research scientists to do whatever they wish.
The Vacating of the Middle Ground
What causes me particular anxiety is that these events are driving the advocates of animal research to adopt more and more-extreme positions and to actively pursue more-militant policies. They claim that the UK has the strongest animal protection legislation in the world, while at the same time trying to weaken it, for example, by tackling "the growing bureaucracy involved in the project licensing system". 9 Meanwhile, the Royal Society has just published a guide for researchers, which blatantly promotes the use of non-human animals in research, 10 and organisations such as the Biomedical Research Education Trust and the Coalition for Medical Progress seem to be seeking to polarise the debate in ways which used to be the preferred device of organisations toward the other end of the spectrum, such as the British Union for the Abolition of Vivisection 
Editorial
The Need for Recommitment to the Three Rs and to Serving Together in the Middle Ground (BUAV) and the National Anti-vivisection Society (NAVS). Nevertheless, I was encouraged to see a critical appraisal in the British Medical Journal, no less, of the claim that animal research benefits humans. 11 Pound et al., writing on behalf of the Reviewing Animal Trials Systematically (RATS) Group, stated that, although it is often considered to be "axiomatic that animal research has contributed to the treatment of human disease", "little evidence is available to support this view". "Anecdotal evidence or unsupported claims are often used as justification", including "statements that the need for animal research is 'self evident'". They go further, stating that "much animal research into potential treatments for humans is wasted because it is poorly conducted and not evaluated through systematic reviews".
Symptomatic of the current situation was that Pound et al. were attacked in a sycophantic and shallow little piece in The Times, 12 written by Mark Henderson, the paper's science correspondent, who can always be relied upon to support the Scientific Establishment whenever he is summoned to their aid. His argument, apparently made on behalf of the MRC, that "the anti-vivisection lobby, or at least its law-abiding element, have had something of an epiphany" was based on one example -"endothelin, a naturally occurring protein [which] is the most potent known substance for raising blood pressure". I assume that he used "epiphany" to mean "a comprehension of reality by means of a sudden intuitive realisation" or "a sudden manifestation of the meaning of something". If so, he is quite wrong. While it may be true that a majority of the general public accept the need for some use of animals in medical research, this does not mean that they are "comfortable" with it (his word). In a poll conducted in 2002 by MORI for the Coalition for Medical Progress and paid for by the MRC, 13,14 67% of respondents were "fairly/very concerned about the use of animals in medical research", and 89% agreed that "there needs to be more research into alternatives to animal experimentation". If there is a need for an epiphany, it is in the minds of those who direct the MRC, the Wellcome Trust, etc., and who pontificate in the columns of newspapers such as The Times.
Nevertheless, if Pound et al. are even half right, their analysis is an indictment of the operation of the Animals (Scientific Procedures) Act 1986, as well as strengthening the position of those of us who, while neither sinister extremists nor noisy ladies, are opposed to much of the animal research conducted in the UK, including that on nonhuman primates, because the scientific case for doing it has yet to be made convincing. To say that the work is necessary, merely because people in Cambridge want to do it, is just not good enough.
Regrouping in the Middle Ground
The result of the increasing militancy of the research defenders is that the middle ground, where FRAME once operated virtually alone, but which later became very crowded, is now becoming less and less congested -a gap is opening up, as indicated by the comment from the RDS that "the aspect [of the Cambridge Laboratory] that attracted the opposition of . . . even moderate organisations such as the RSPCA [Royal Society for the Prevention of Cruelty to Animals] and FRAME" was that "it was dedicated to using primates". 15 How can this have been such a surprise to the RDS? Both the RSPCA and FRAME have been questioning the use of primates as laboratory animals for decades! I fully concur with the following statement by Richard Smith, Editor of the British Medical Journal, 16 made in 2001 in an editorial entitled Animal research: the need for a middle ground:
The arguments over animal research are so polarised because the two sides have completely different ways of thinking. Opponents of research are concerned primarily with the rights and suffering of animals, whereas supporters are interested in the capacity of animal research to speed developments in understanding biology and preventing and treating disease. We need methods to promote agreement rather than disagreement and the Three Rs can do just that. The beauty of the Three Rs is that they provide a way for all parties to work together to advance the cause of both animals and humans.
We do need the middle ground, and I hope that the MRC, RDS, etc. will soon rejoin us there, so that we can continue the debate (which has not been won, despite what Mark Matfield of the RDS may wish to think 6 ) and return to working together to make orderly progress toward the reduction, refinement and replacement of animal procedures, in the interests of humans and animals, as well as science and ethics. I have written to Colin Blakemore, Chief Executive of the MRC, to propose just that. I await his reply.
The Need for Urgency
There are two other reasons why current events cause concern and why underlying questions need to be resolved.
Firstly, the Government have just announced a 10-year plan to strengthen medical research in the UK, with funding for clinical research and development within the National Health Service alone, including an extra £100m for the MRC, set to reach £1.2bn per year by 2008. 17 Secondly, the Government will shortly announce a detailed plan to estab-lish a national centre to promote alternatives to animal experimentation. 18 Both these developments deserve a cautious welcome, since they have enormous implications and great potential value. They could, as the Government hopes, secure the UK as a world leader in medical research and the delivery of new treatments, but not if control of the additional funding and of the alternatives centre were to fall into the hands of those who see the building of new primate research centres as the essential way of doing medical research in the 21st century.
Only much clearer signs of a genuine and active commitment to the Three Rs at all levels -government, industry, science, academia -will convince me that my worries are unfounded.
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